MMRGlobal to Launch Innovative Scanning Solution at HIMSS 2014

LOS ANGELES, CA--(Marketwired - Feb 18, 2014) - MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), today announced that it will launch MMRProPlus at the HIMSS14 Annual Conference & Exhibition starting next week on February 23^rd in Orlando, Florida, Booth #875 (www.HIMSSConference.org). MMRProPlus is an integrated, end-to-end document scanning and imaging solution that works with any scanner. MMRProPlus also brings the power of the original MMRPro system to any healthcare professional including small group medical practices, urgent care facilities, ambulatory surgical centers and hospitals. The MMRProPlus system has been designed to work with virtually any Windows-based or Mac OS system at one-third the cost of the original MMRPro network scanning solution. MMRProPlus is the most cost-effective way for healthcare professionals to scan and digitize medical records while also providing patients timely online access to their personal health information through MMRPatientView or MyMedicalRecords.

MMRProPlus also integrates seamlessly with most existing practice management and EMR systems. Users of the MMRProPlus system simply install MMRProPlus drivers on the PC that is connected to the scanner to be used. If the scanner is wireless then multiple PCs can be configured. Nothing is installed on a scanner, everything happens on the client PC. The system also enables providers to create custom patient forms on demand and tracks patient data and medical records using advanced bar code capture technology.

Visitors to HIMSS14 can see MMRProPlus and MMR's entire lineup of products and services in Booth #875, February 23^rd through the 26^th. Also presenting in the booth will be Company licensees 4medica and Interbit Data.

All of MMRGlobal's products and services, including the new MMRProPlus system, the MyMedicalRecords Personal Health Record, MyEsafeDepositBox.com virtual vault, and MMRPatientView utilize MMR's patented technologies which include ten U.S. patents: U.S. Patent Nos. 8,117,045; 8,117,646; 8,121,855; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883; 8,626,532; and 8,645,161. The MMR patent portfolio also includes numerous issued patents and pending applications in other countries or regional authorities of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, China, Hong Kong, South Korea, Israel and Europe. Using MMRPro, healthcare professionals can move away from handling paper based records while seamlessly integrating with most EMR, EHR or PHR systems mandated under the HITECH Act, paving the way for the implementation of fully-functional interoperable certified EMR systems.

About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, including, without limitation, future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMR's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk MMR's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in MMR's filings with the Securities and Exchange Commission. MMR is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.